Levenra 500 Tablet
Marketer
Jamrex Biotech Pvt Ltd
Salt Composition
Levetiracetam (500mg)
Overview Levenra 500 Tablet
Epileptic seizures are managed with Levetiracetam 500mg tablets, an anticonvulsant medication. This medication, used either independently or in combination with other treatments, effectively controls seizures provided consistent use is maintained. Levetiracetam works by reducing abnormal brain electrical activity. Administration is flexible, with or without food, but consistent daily timing optimizes therapeutic effect. Dosage is individualized, guided by your health status and response, and determined by your physician. Long-term therapy is typically recommended, and discontinuation should only occur under medical supervision. Premature cessation or missed doses can exacerbate seizures. Common, generally transient side effects include headache, irritability, drowsiness, altered behavior (including aggression), and reduced appetite. While most side effects resolve spontaneously, some warrant medical attention. Suicidal ideation, though rare, has been reported; promptly notify your doctor of any mood deterioration. Prior to commencement, disclose any kidney impairment, depression, suicidal tendencies, pregnancy, pregnancy plans, or breastfeeding to your physician. Regular blood tests to monitor renal function may be recommended during treatment.
Uses of Levenra 500 Tablet
Managing Epileptic Seizures
Major Benefits of Levenra 500 Tablet:
Administer Levenra 500 Tablet as prescribed by your physician, ingesting the medication whole. Avoid chewing, crushing, or fracturing the tablet. This medication can be taken with or without food; however, consistent timing is recommended.
Common Side effects of Levenra 500 Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Levenra 500 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Levenra 500 Tablets can be consumed with or without food, though consistent timing is recommended.
How Levenra 500 Tablet works:
Levenra 500 mg tablets are used to treat epilepsy. Their mechanism involves binding to SV2A receptors located on neuronal membranes. This action reduces excessive neuronal firing in the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Combining Levenra 500 Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of Levenra 500 Tablet during pregnancy is considered safe. Research largely indicates minimal or absent risk to the fetus.
Breast feedingSAFE IF PRESCRIBED
Using Levenra 500 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. Observe the infant for drowsiness and appropriate weight increase.
DrivingUNSAFE
Taking Levenra 500 Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these side effects appear.
KidneyCAUTION
Patients with kidney impairment should use Levenra 500 Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Levenra 500 Tablet in patients with liver impairment is generally considered safe. Available evidence indicates dose modification may be unnecessary for most; however, individuals with severe hepatic dysfunction might benefit from a reduced dosage. Physician consultation is recommended.
What if you forget to take Levenra 500 Tablet :
Should you forget to take your Levenra 500 Tablet, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Levenra 500 Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinone-Acetamide Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | AED: A protein ligand within synaptic vesicle 2 |



